v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A 12% Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Deficit [Member]
Total
Beginning balance at Dec. 31, 2023         $ 1,723
Beginning balance (in Shares) at Dec. 31, 2023         176
Ending balance at Dec. 31, 2024         $ 1,723
Ending balance (in Shares) at Dec. 31, 2024         176
Beginning balance at Dec. 31, 2023 $ 500 $ 61 $ 291,847 $ (354,372) $ (61,964)
Beginning balance (in Shares) at Dec. 31, 2023 1,235,000 61,852,914      
Series A 12% convertible preferred stock dividend     64 (64)  
Series A 12% convertible preferred stock dividend (in Shares)   24,700      
Series C super dividend redeemable convertible preferred stock dividend     89 (89)  
Series C super dividend redeemable convertible preferred stock dividend (in Shares)   35,200      
Issuance of common stock from exercise of warrants   $ 1 427   428
Issuance of common stock from exercise of warrants (in Shares)   142,370      
Issuance of common stock from exercise of stock options, net of shares withheld for exercise     799   $ 799
Issuance of common stock from exercise of stock options, net of shares withheld for exercise (in Shares)   473,370     503,333
Issuance of common stock from restricted stock units (in Shares)   378,000      
Issuance of common stock purchase warrants in connection with related party line of credit     845   $ 845
Stock-based compensation expense     2,146   2,146
Stock-based compensation expense (in Shares)   250,548      
Net loss       (47,047) (47,047)
Ending balance at Dec. 31, 2024 $ 500 $ 62 296,217 (401,572) (104,793)
Ending balance (in Shares) at Dec. 31, 2024 1,235,000 63,157,235      
Ending balance at Dec. 31, 2025         $ 1,723
Ending balance (in Shares) at Dec. 31, 2025         176
Series A 12% convertible preferred stock dividend     67 (67)  
Series A 12% convertible preferred stock dividend (in Shares)   24,450      
Series C super dividend redeemable convertible preferred stock dividend     71 (71)  
Series C super dividend redeemable convertible preferred stock dividend (in Shares)   29,032      
Conversion of Series A convertible preferred to common stock $ (10)   10    
Conversion of Series A convertible preferred to common stock (in Shares) (25,000) 4,167      
Issuance of common stock from exercise of warrants (in Shares)   10      
Issuance of common stock from exercise of stock options, net of shares withheld for exercise   $ 1 2,239   $ 2,240
Issuance of common stock from exercise of stock options, net of shares withheld for exercise (in Shares)   1,090,164     1,090,164
Issuance of common stock   $ 1 3,234   $ 3,235
Issuance of common stock (in Shares)   792,537      
Issuance of common stock purchase warrants in connection with related party line of credit     667   667
Stock-based compensation expense   $ 1 1,568   1,569
Stock-based compensation expense (in Shares)   104,400      
Net loss       (30,836) (30,836)
Ending balance at Dec. 31, 2025 $ 490 $ 65 $ 304,073 $ (432,546) $ (127,918)
Ending balance (in Shares) at Dec. 31, 2025 1,210,000 65,201,995